{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:51:07Z","timestamp":1776437467561,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The First Affiliated Hospital of Kunming Medical University, Master's Degree Innovation Fund Project","award":["2024S245"],"award-info":[{"award-number":["2024S245"]}]},{"name":"Priority Union\u00a0Foundation of Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["202301AY070001-183"],"award-info":[{"award-number":["202301AY070001-183"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive form of non-Hodgkin lymphoma with heterogeneous molecular characteristics. Altered metabolism, particularly mitochondrial function, has emerged as a critical factor in cancer progression. However, the role of mitochondrial metabolism in DLBCL remains poorly understood. This study aimed to identify key mitochondrial factors associated with DLBCL progression. We analyzed transcriptomic data from multiple DLBCL datasets (GSE83632, TCGA\u2013GTEX, GSE181063, GSE4475) using differential expression analysis, weighted gene co-expression network analysis (WGCNA), and Gene Set Enrichment Analysis (GSEA). The expression and function of the identified key factor, Mitochondrial Pyruvate Carrier 2 (MPC2), were validated using clinical samples, DLBCL cell lines, and an in vivo mouse model of xenograft. Integrative bioinformatics analysis identified MPC2 as a significantly upregulated gene in DLBCL, associated with enrichment of oxidative phosphorylation (OXPHOS) and cell cycle-related genes. MPC2 overexpression was confirmed in clinical DLBCL samples and cell lines at both mRNA and protein levels. Knockdown of MPC2 in DLBCL cells impaired mitochondrial OXPHOS, increased glycolysis, and suppressed cell proliferation, invasion, and 3D spheroid formation. In vivo, MPC2 silencing significantly reduced tumor growth in a xenograft mouse model. Our findings reveal MPC2 as a key regulator of mitochondrial function in DLBCL, promoting tumor progression through enhanced OXPHOS. This study provides new insights into the metabolic reprogramming of DLBCL and suggests MPC2 as a potential therapeutic target for this aggressive lymphoma.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s10528-025-11100-8","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T05:12:14Z","timestamp":1745730734000},"page":"1859-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MPC2 Overexpression Drives Mitochondrial Oxidative Phosphorylation and Promotes Progression in Diffuse Large B-Cell Lymphoma"],"prefix":"10.1007","volume":"64","author":[{"given":"Haoneng","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinguang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"11100_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.604143","volume":"10","author":"A Barbato","year":"2020","unstructured":"Barbato A, Scandura G, Puglisi F, Cambria D, La Spina E, Palumbo GA et al (2020) Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: an overview. Front Oncol 10:604143","journal-title":"Front Oncol"},{"issue":"2","key":"11100_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.cmet.2019.11.002","volume":"31","author":"CL Bensard","year":"2020","unstructured":"Bensard CL, Wisidagama DR, Olson KA, Berg JA, Krah NM, Schell JC et al (2020) Regulation of tumor initiation by the mitochondrial pyruvate carrier. Cell Metab 31(2):284-300.e7","journal-title":"Cell Metab"},{"issue":"9","key":"11100_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2019.05.005","volume":"29","author":"S Bose","year":"2019","unstructured":"Bose S, Ramesh V, Locasale JW (2019) Acetate metabolism in physiology, cancer, and beyond. Trends Cell Biol 29(9):695\u2013703","journal-title":"Trends Cell Biol"},{"issue":"8","key":"11100_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.3390\/biom10081162","volume":"10","author":"JL Buchanan","year":"2020","unstructured":"Buchanan JL, Taylor EB (2020) Mitochondrial pyruvate carrier function in health and disease across the lifespan. Biomolecules 10(8):1162","journal-title":"Biomolecules"},{"issue":"1","key":"11100_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41420-023-01475-1","volume":"9","author":"Y Cai","year":"2023","unstructured":"Cai Y, Lv L, Lu T, Ding M, Yu Z, Chen X, Zhou X, Wang X (2023) \u03b1-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis. Cell Death Discov 9(1):182","journal-title":"Cell Death Discov"},{"issue":"4","key":"11100_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro P, Kishan AU, Norberg E, Stanley IA, Chapuy B, Ficarro SB et al (2012) Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22(4):547\u2013560","journal-title":"Cancer Cell"},{"issue":"5","key":"11100_CR7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24(5):679\u2013690","journal-title":"Nat Med"},{"issue":"21","key":"11100_CR8","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1073\/pnas.1016627108","volume":"108","author":"T Cheng","year":"2011","unstructured":"Cheng T, Sudderth J, Yang C, Mullen AR, Jin ES, Mat\u00e9s JM et al (2011) Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci USA 108(21):8674\u20138679","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"11100_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41467-018-03525-0","volume":"9","author":"C Corbet","year":"2018","unstructured":"Corbet C, Bastien E, Draoui N, Doix B, Mignion L, Jordan BF et al (2018) Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects. Nat Commun 9(1):1208","journal-title":"Nat Commun"},{"issue":"16","key":"11100_CR10","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M, Neelapu SS, Farooq U, Van Den Neste E, Kuruvilla J, Westin J, Link BK, Hay A, Cerhan JR, Zhu L, Boussetta S, Feng L, Maurer MJ, Navale L, Wiezorek J, Go WY, Gisselbrecht C (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130(16):1800\u20131808","journal-title":"Blood"},{"key":"11100_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824704","volume":"12","author":"W Daneels","year":"2022","unstructured":"Daneels W, Rosskamp M, Macq G, Saadoon EI, De Geyndt A, Offner F, Poirel HA (2022) Real-world estimation of first- and second-line treatments for diffuse large B-cell lymphoma using health insurance data: a Belgian population-based study. Front Oncol 12:824704","journal-title":"Front Oncol"},{"issue":"4","key":"11100_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ccr.2012.09.023","volume":"22","author":"RJ Deberardinis","year":"2012","unstructured":"Deberardinis RJ (2012) A mitochondrial power play in lymphoma. Cancer Cell 22(4):423\u2013424","journal-title":"Cancer Cell"},{"issue":"5","key":"11100_CR13","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/1878-0261.13115","volume":"16","author":"G Donati","year":"2022","unstructured":"Donati G, Rav\u00e0 M, Filipuzzi M, Nicoli P, Cassina L, Verrecchia A et al (2022) Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma. Mol Oncol 16(5):1132\u20131152","journal-title":"Mol Oncol"},{"issue":"6487","key":"11100_CR14","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ (2020) Metabolic reprogramming and cancer progression. Science 368(6487):eaaw5473","journal-title":"Science"},{"issue":"9","key":"11100_CR15","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1016\/j.radcr.2023.05.068","volume":"18","author":"SC Goh","year":"2023","unstructured":"Goh SC, Ngai S (2023) The clinical challenge of relapsed diffuse large B-cell lymphoma with disseminated infection. Radiol Case Rep 18(9):3046\u20133053","journal-title":"Radiol Case Rep"},{"issue":"3","key":"11100_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1053\/j.seminoncol.2017.10.002","volume":"44","author":"M Gooptu","year":"2017","unstructured":"Gooptu M, Whitaker-Menezes D, Sprandio J, Domingo-Vidal M, Lin Z, Uppal G et al (2017) Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma. Semin Oncol 44(3):204\u2013217","journal-title":"Semin Oncol"},{"issue":"14","key":"11100_CR17","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1007\/s00018-013-1539-2","volume":"71","author":"LR Gray","year":"2014","unstructured":"Gray LR, Tompkins SC, Taylor EB (2014) Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci 71(14):2577\u20132604","journal-title":"Cell Mol Life Sci"},{"issue":"7598","key":"11100_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature17393","volume":"532","author":"L Jiang","year":"2016","unstructured":"Jiang L, Shestov AA, Swain P, Yang C, Parker SJ, Wang QA et al (2016) Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532(7598):255\u2013258","journal-title":"Nature"},{"issue":"9","key":"11100_CR18","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1111\/cas.15055","volume":"112","author":"D Jiang","year":"2021","unstructured":"Jiang D, Mo Q, Sun X, Wang X, Dong M, Zhang G, Chen F, Zhao Q (2021) Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1\/CD20. Cancer Sci 112(9):3585\u20133597","journal-title":"Cancer Sci"},{"issue":"9","key":"11100_CR20","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/cdd.2011.17","volume":"18","author":"PN Kelly","year":"2011","unstructured":"Kelly PN, Strasser A (2011) The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ 18(9):1414\u20131424","journal-title":"Cell Death Differ"},{"issue":"4","key":"11100_CR21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cancers12040938","volume":"12","author":"M Klanova","year":"2020","unstructured":"Klanova M, Klener P (2020) BCL-2 proteins in pathogenesis and therapy of B-cell non-Hodgkin lymphomas. Cancers (Basel) 12(4):938","journal-title":"Cancers (Basel)"},{"key":"11100_CR22","doi-asserted-by":"publisher","first-page":"6618837","DOI":"10.1155\/2021\/6618837","volume":"2021","author":"M Kuerbanjiang","year":"2021","unstructured":"Kuerbanjiang M, Gu L, Xu C, Xu WT, Wen S, Xue H, Xu Q (2021) Decreased expression of MPC2 contributes to aerobic glycolysis and colorectal cancer proliferation by activating mTOR pathway. J Immunol Res 2021:6618837","journal-title":"J Immunol Res"},{"issue":"1","key":"11100_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1186\/s12885-016-2941-6","volume":"16","author":"X Li","year":"2016","unstructured":"Li X, Ji Y, Han G, Li X, Fan Z, Li Y et al (2016) MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer. BMC Cancer 16(1):894","journal-title":"BMC Cancer"},{"issue":"1","key":"11100_CR24","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.18632\/oncotarget.13717","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li X, Kan Q, Zhang M, Li X, Xu R et al (2017) Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas. Oncotarget 8(1):1058\u20131073","journal-title":"Oncotarget"},{"issue":"1","key":"11100_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ (2018) Diffuse large B-cell lymphoma. Pathology 50(1):74\u201387","journal-title":"Pathology"},{"issue":"1","key":"11100_CR26","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1038\/s41598-018-21740-z","volume":"8","author":"RSK Nagampalli","year":"2018","unstructured":"Nagampalli RSK, Ques\u00f1ay JEN, Adamoski D, Islam Z, Birch J, Sebinelli HG et al (2018) Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter. Sci Rep 8(1):3510","journal-title":"Sci Rep"},{"issue":"2","key":"11100_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/cdd.2016.116","volume":"24","author":"E Norberg","year":"2017","unstructured":"Norberg E, Lako A, Chen PH, Stanley IA, Zhou F, Ficarro SB et al (2017) Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets. Cell Death Differ 24(2):251\u2013262","journal-title":"Cell Death Differ"},{"issue":"3","key":"11100_CR28","first-page":"1276","volume":"39","author":"T Ohashi","year":"2018","unstructured":"Ohashi T, Eguchi H, Kawamoto K, Konno M, Asai A, Colvin H et al (2018) Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma. Oncol Rep 39(3):1276\u20131282","journal-title":"Oncol Rep"},{"issue":"3","key":"11100_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tibs.2016.01.002","volume":"41","author":"KA Olson","year":"2016","unstructured":"Olson KA, Schell JC, Rutter J (2016) Pyruvate and metabolic flexibility: illuminating a path toward selective cancer therapies. Trends Biochem Sci 41(3):219\u2013230","journal-title":"Trends Biochem Sci"},{"issue":"21","key":"11100_CR30","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","volume":"131","author":"L Pasqualucci","year":"2018","unstructured":"Pasqualucci L, Dalla-Favera R (2018) Genetics of diffuse large B-cell lymphoma. Blood 131(21):2307\u20132319","journal-title":"Blood"},{"issue":"1","key":"11100_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347","journal-title":"Cell Metab"},{"issue":"7","key":"11100_CR32","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.3390\/cancers13071488","volume":"13","author":"A Ruiz-Iglesias","year":"2021","unstructured":"Ruiz-Iglesias A, Ma\u00f1es S (2021) The importance of mitochondrial pyruvate carrier in cancer cell metabolism and tumorigenesis. Cancers (Basel) 13(7):1488","journal-title":"Cancers (Basel)"},{"issue":"3","key":"11100_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","volume":"56","author":"JC Schell","year":"2014","unstructured":"Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J et al (2014) A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell 56(3):400\u2013413","journal-title":"Mol Cell"},{"issue":"11","key":"11100_CR34","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1158\/1535-7163.MCT-22-0718","volume":"22","author":"A Schwarzer","year":"2023","unstructured":"Schwarzer A, Oliveira M, Kleppa MJ, Slattery SD, Anantha A, Cooper A et al (2023) Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1. Mol Cancer Ther 22(11):1290\u20131303","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"11100_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G (2021) Diffuse large B-cell lymphoma. N Engl J Med 384(9):842\u2013858","journal-title":"N Engl J Med"},{"issue":"516","key":"11100_CR36","doi-asserted-by":"publisher","first-page":"eaax2863","DOI":"10.1126\/scitranslmed.aax2863","volume":"11","author":"D Sharon","year":"2019","unstructured":"Sharon D, Cathelin S, Mirali S, Di Trani JM, Yanofsky DJ, Keon KA et al (2019) Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response. Sci Transl Med 11(516):eaax2863","journal-title":"Sci Transl Med"},{"issue":"4","key":"11100_CR37","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/cas.13980","volume":"110","author":"Y Takaoka","year":"2019","unstructured":"Takaoka Y, Konno M, Koseki J, Colvin H, Asai A, Tamari K et al (2019) Mitochondrial pyruvate carrier 1 expression controls cancer epithelial\u2013mesenchymal transition and radioresistance. Cancer Sci 110(4):1331\u20131339","journal-title":"Cancer Sci"},{"issue":"4","key":"11100_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMoa2115304","volume":"386","author":"H Tilly","year":"2022","unstructured":"Tilly H, Morschhauser F, Sehn LH, Friedberg JW, Trn\u011bn\u00fd M, Sharman JP et al (2022) Polatuzumab Vedotin in previously untreated diffuse large B-cell lymphoma. N Engl J Med 386(4):351\u2013363","journal-title":"N Engl J Med"},{"issue":"3","key":"11100_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and cancer. Cell 166(3):555\u2013566","journal-title":"Cell"},{"issue":"39","key":"11100_CR40","doi-asserted-by":"publisher","first-page":"eabq0117","DOI":"10.1126\/sciadv.abq0117","volume":"8","author":"P Wei","year":"2022","unstructured":"Wei P, Bott AJ, Cluntun AA, Morgan JT, Cunningham CN, Schell JC et al (2022) Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2-dependent glutaminolysis pathway. Sci Adv 8(39):eabq0117","journal-title":"Sci Adv"},{"issue":"1","key":"11100_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","volume":"11","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Chandel NS (2015) Targeting mitochondria metabolism for cancer therapy. Nat Chem Biol 11(1):9\u201315","journal-title":"Nat Chem Biol"},{"issue":"1","key":"11100_CR42","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12935-021-01996-8","volume":"21","author":"C Xue","year":"2021","unstructured":"Xue C, Li G, Bao Z, Zhou Z, Li L (2021) Mitochondrial pyruvate carrier 1: a novel prognostic biomarker that predicts favourable patient survival in cancer. Cancer Cell Int 21(1):288","journal-title":"Cancer Cell Int"},{"key":"11100_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106019","volume":"127","author":"S Yao","year":"2022","unstructured":"Yao S, Yin J, Liu W, Li Y, Huang J, Qi C, Hu Z, Tong Q, Gu L, Zhang Y (2022) A novel Gboxin analog induces OXPHOS inhibition and mitochondrial dysfunction-mediated apoptosis in diffuse large B-cell lymphoma. Bioorg Chem 127:106019","journal-title":"Bioorg Chem"},{"issue":"5","key":"11100_CR44","doi-asserted-by":"publisher","first-page":"4954","DOI":"10.3390\/ijms24054954","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Wei Y, Yuan S, Sun L (2023) Targeting mitochondrial metabolic reprogramming as a potential approach for cancer therapy. Int J Mol Sci 24(5):4954","journal-title":"Int J Mol Sci"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11100-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11100-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11100-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:03:18Z","timestamp":1776434598000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11100-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["11100"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11100-8","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The use of human samples gained the approval of Ethics Committee of the First Affiliated Hospital of Kunming Medical University [(2024) Lunshen L No. 227]. All the sample handling and data processing steps were following the Declaration of Helsinki.Animal protocols were in compliance with the guidelines of animal care and welfare and were approved by Ethical Review Committee for Animal Experiments of Kunming Medical University (kmmu20241762).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All the recruited subjects signed the written-informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}